H elicobacter pylori infection is acquired primarily in early childhood and is predominantly transmitted within families, infected mother and siblings being the most common familial source of the microorganism (1-5). Infants and toddlers most frequently acquire and lose the infection (3, 6), but there are substantial knowledge gaps in respect to the predictors of initial acquisition, as well as the persistence of the infection, in this age group. In addition, in children, H. pylori infection has been associated with iron deficiency anemia, diarrheic disease, and impairment of growth, weight, and cognitive functions (7,8). Thus, a simple and reliable noninvasive test to detect H. pylori infection in this age group is required, especially in developing countries, where the prevalence of H. pylori infection is very high.The noninvasive [ 13 C]urea breath test ([ 13 C]UBT) (9-12) and stool antigen test (13-15) are very reliable for the diagnosis of H. pylori infection in children older than 6 years. The stool test based on monoclonal antibodies has proved to be highly accurate in all age groups (13-15), but the specificity of the [ 13 C]UBT varies from 82% to 100% for young children (9-12). However, studies of this subject are scarce and have not included large enough numbers of infants and toddlers to obtain reliable results. Furthermore, different "gold standard" tests have been used to validate the [ 13 C]UBT, and most studies are in developed countries, where the prevalence of infection is very low (11,12,16,17).To validate noninvasive tests for diagnosis of H. pylori infection, the indicated "gold standard" includes at least two invasive tests, which is a difficult task with young children due to the current rarity of symptomatic H. pylori infection in this period of life. In addition, as stated by Goodman and Correa, validation using invasive tests has some limitations; recent short-term colonization and patchy distribution of the bacterium in the gastric mucosa may decrease the sensitive of biopsy-based tests in very young children (18). Such problems currently restrict epidemiological investigations of the acquisition of H. pylori infection in infants and toddlers in developing-country settings.The aim of this study was to investigate whether the two independent noninvasive tests for H. pylori infection diagnosis, the [ 13 C]UBT and monoclonal stool antigen test, have good concordance in young children. For that, we evaluated a cohort of infants and toddlers living in impoverished regions of two developing countries in South America. Our hypothesis was that if the [ 13 C]UBT and monoclonal stool antigen test had good agreement in infants and toddlers, either of the two noninvasive tests could be used for the diagnosis of H. pylori in this age group. We also aimed to investigate causes linked to discordant results between the two tests.